From my basic research, Cognigram has been available in Canada since 2013, but I can't find much information from company reports regarding the level of market penetration or revenue that it has garnered... Do you believe that Cognigram will be a bigger commercial success in the United States? Don't get me wrong, I work in the cognitive sciences area, and can totally understand that Cognigram would be a fantastic product that provides a much-needed update to traditional pen/paper practises of screening for dementia/cognitive impairment. It would be great to hear how the company has learned from Canada in terms of whether they will tweak pricing/marketing tactics for the U.S. rollout. I guess more information in this regard will be provided across FY18.
Hoping to take up a (relatively) small-moderate position in CGS as more Cognigram info is provided.
Cheers
- Forums
- ASX - By Stock
- CGS
- Ann: Cogstate selected as preferred provider for Lilly
Ann: Cogstate selected as preferred provider for Lilly, page-10
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGS (ASX) to my watchlist
|
|||||
Last
$1.15 |
Change
-0.025(2.14%) |
Mkt cap ! $193.8M |
Open | High | Low | Value | Volume |
$1.14 | $1.16 | $1.14 | $59.08K | 51.83K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4728 | $1.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.15 | 1999 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3217 | 1.145 |
1 | 2157 | 1.140 |
3 | 17135 | 1.135 |
1 | 9403 | 1.130 |
1 | 10000 | 1.100 |
Price($) | Vol. | No. |
---|---|---|
1.150 | 1999 | 3 |
1.155 | 437 | 1 |
1.160 | 1000 | 1 |
1.200 | 10232 | 1 |
1.240 | 3478 | 1 |
Last trade - 11.44am 19/07/2024 (20 minute delay) ? |
Featured News
CGS (ASX) Chart |